Poland· PL-100292867
Maść majerankowa
A medicinal product containing majoranae unguentum, registered in Poland by Zakład Farmaceutyczny "Amara" Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Majoranae unguentum
- Manufacturer
- Zakład Farmaceutyczny "Amara" Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991040048
- gtin05909991040024
- gtin05909991040031
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb7c3131-0898-4369-9cef-5528a6817234 GET /v1/drugs/bb7c3131-0898-4369-9cef-5528a6817234?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "-",
"packaging": "05909991040024 ¦ OTC ¦ 82140\n1 op. 10 g\n05909991040031 ¦ OTC ¦ 82141\n1 op. 15 g\n05909991040048 ¦ OTC ¦ 82142\n1 op. 20 g",
"substance": "Majoranae herba extractum 100 g/100 g",
"common_name": "Majoranae unguentum",
"pl_product_id": "100292867",
"pozwolenie_nr": "20902",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about majoranae unguentum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.